Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

Share Price is delayed by 15 minutes
Get Live Data
103.20    -5.80 (-5.32%)
Bid:
103.00
Ask:
104.20
Spread: 1.20 (1.165%)
Market Cap: £169.19m
SYNT Live PriceLast checked at - London Stock Exchange

Intraday Synthomer Share Chart

Statement re potential refinancing

11 Feb 2026 13:46

RNS Number : 6402S
Synthomer PLC
11 February 2026
 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS FOR INFORMATION PURPOSES ONLY AND DOES NOT CONSTITUTE AN OFFER OF SECURITIES IN ANY JURISDICTION.

THIS ANNOUNCEMENT IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION IN WHICH SUCH PUBLICATION, RELEASE OR DISTRIBUTION WOULD CONSTITUTE A BREACH OF ANY LAW OR REGULATION OF THAT JURISDICTION.

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION. FOR IMMEDIATE RELEASE

 

11 February 2026

 

Synthomer plc

Statement regarding potential refinancing

 

Synthomer plc ("Synthomer" or the "Company") notes the recent media speculation regarding the possibility of the Company undertaking a capital raise.

The Company confirms that it is in the process of working with lenders to refinance its existing debt facilities due in H2 2027. In support of this refinancing, the Company is giving consideration to a range of options to reduce the Company's leverage and underpin the sustained delivery of its speciality chemicals strategy, including the possibility of raising additional capital.

No decisions have been made as to whether, when or on what terms any such options may be undertaken, and further announcements will be made as appropriate.

The person responsible for making this announcement on behalf of Synthomer is Anant Prakash, General Counsel & Company Secretary.

 

Further information:

 

Investors: Faisal Tabbah, Vice President Investor Relations

Tel: +44 (0) 1279 775 306

Media: Nick Hasell, FTI Consulting

Tel: +44 (0) 203 727 1234

 

Notes

 

Synthomer plc is a leading supplier of high-performance, highly specialised polymers and ingredients that play vital roles in key sectors such as coatings, construction, adhesives, and health and protection - growing markets for customers who serve billions of end users worldwide. Headquartered in London, UK and listed there since 1971, we employ c.3,800 employees across our five innovation centres of excellence and 29 manufacturing sites across Europe, North America, the Middle East and Asia. With more than 6,000 blue-chip customers and £2.0bn in continuing revenue in 2024, our business is built around three divisions, serving customers in attractive end markets where demand is driven by global megatrends including urbanisation, demographic change, climate change and sustainability, and shifting economic power.

 

In Coatings & Construction Solutions, our specialist polymers enhance the sustainability and performance of a wide range of coatings and construction products. We serve customers in applications including architectural and masonry coatings, mortar modification, waterproofing and flooring, fibre bonding, and energy solutions. In Adhesive Solutions our products help our customers bond, modify and compatibilise surfaces and components for applications including tapes and labels, packaging, hygiene, tyres and plastic modification, improving permeability, strength, elasticity, damping, dispersion and grip. In Health & Protection and Performance Materials we are a world-leading supplier of water-based polymers for medical gloves, and a major European manufacturer of high-performance binders, foams and other products serving customers in a range of end markets.

 

Our purpose is creating innovative and sustainable solutions for the benefit of customers and society. Around 20% of our sales volumes are from new and patent protected products. At our innovation centres of excellence in the UK, China, Germany, Malaysia and Ohio, USA we collaborate closely with our customers to develop new products and enhance existing ones tailored to their needs, with an increasing range of sustainability benefits. Our 2030 decarbonisation targets have been approved by the Science Based Targets initiative as being in line with what the latest climate science says is necessary to meet the goals of the Paris Agreement, and since 2021 we have held the London Stock Exchange Green Economy Mark, which recognises green technology businesses making a significant contribution to a more sustainable, low-carbon economy. Find us at www.synthomer.com or search for Synthomer on LinkedIn. Legal Entity Identifier (LEI): 213800EHT3TI1KPQQJ56.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
SPCDZGMZFMDGVZM
Date   Source Headline
14th Oct 20133:55 pmRNSHolding(s) in Company
22nd Aug 201311:18 amRNSHolding(s) in Company
16th Aug 201312:36 pmRNSDirector/PDMR Shareholding
13th Aug 20137:00 amRNSInterim Results
12th Aug 20131:37 pmRNSHolding(s) in Company
7th Aug 20133:18 pmRNSHolding(s) in Company
4th Jul 20133:37 pmRNSHolding(s) in Company
28th Jun 20134:21 pmRNSHolding(s) in Company
6th Jun 201310:46 amRNSHolding(s) in Company
17th May 20134:33 pmRNSHolding(s) in Company
16th May 20131:07 pmRNSResult of AGM
16th May 20137:00 amRNSInterim Management Statement
2nd May 20134:59 pmRNSHolding(s) in Company
24th Apr 20134:37 pmRNSDirector/PDMR Shareholding
24th Apr 20134:36 pmRNSDirector/PDMR Shareholding
24th Apr 201311:14 amRNSHolding(s) in Company
16th Apr 201311:52 amRNSReplacement Annual Financial Report
16th Apr 20139:29 amRNSAnnual Financial Report
15th Apr 20131:58 pmRNSHolding(s) in Company
9th Apr 201311:52 amRNSDirector/PDMR Shareholding
28th Mar 20139:19 amRNSHolding(s) in Company
19th Mar 20134:31 pmRNSHolding(s) in Company
15th Mar 20137:00 amRNSPreliminary Results
14th Feb 20131:59 pmRNSReplacement Director Declaration
14th Feb 20131:00 pmRNSDirectorate Change
13th Feb 201311:23 amRNSHolding(s) in Company
7th Feb 201312:26 pmRNSDirectorate Change
1st Feb 20134:37 pmRNSDirector Declaration
19th Dec 201210:08 amRNSReplacement Holding(s) in Company
17th Dec 201210:11 amRNSDirector Declaration
14th Dec 201212:38 pmRNSReplacement Holding(s) in Company
14th Dec 201212:27 pmRNSDirector Declaration
6th Dec 20124:35 pmRNSHolding(s) in Company
4th Dec 201212:17 pmRNSResult of EGM
16th Nov 201211:34 amRNSDirector Declaration
8th Nov 20127:00 amRNSNotice of General Meeting
8th Nov 20127:00 amRNSInterim Management Statement
1st Nov 201212:28 pmRNSHolding(s) in Company
12th Oct 20124:15 pmRNSHolding(s) in Company
5th Oct 20127:00 amRNSDirectorate Change
27th Sep 20122:24 pmRNSHolding(s) in Company
25th Sep 20124:06 pmRNSHolding(s) in Company
10th Sep 20123:38 pmRNSDirector Declaration
6th Sep 20128:58 amRNSHolding(s) in Company
28th Aug 20127:00 amRNSInterim Results 2012
22nd Aug 20125:06 pmRNSHolding(s) in Company
13th Aug 20124:32 pmRNSHolding(s) in Company
24th Jul 201210:23 amRNSHolding(s) in Company
20th Jul 20124:10 pmRNSHolding(s) in Company
16th Jul 20129:33 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.